William Monteith

William (Bill) Monteith, joined StrideBio as Chief Operating Officer in August 2020. Mr. Monteith has nearly 40 years of experience leading clinical development and commercial scale manufacturing, quality, supply chain and facility operations in therapeutics focused companies spanning small molecules, biologics and cell & gene therapies. Prior to joining StrideBio, he was Executive Vice President of Technical Operations at Cellectis. Previous roles have included serving as Chief Operating Officer of Hitachi Chemical Advanced Therapy Solutions and Executive Vice President Technical Operations at Dendreon, where Bill was part of the team that launched the first autologous dendritic immunotherapy in the US. In addition, he has held multiple site operations and quality positions with Sandoz, Shire, and Wyeth. Bill holds a Bachelor of Science in Chemistry from Saint Lawrence University in Canton NY.